Corteva to invest in Evogene's Lavie Bio.

Corteva, a leading pure-play agriculture company, agreed to invest in Evogene's agriculture biologicals subsidiary, Lavie Bio. Financial terms were not disclosed. Susanne Wasson, Crop Protection Business Platform President for Corteva Agriscience said, "This transaction demonstrates Corteva's ongoing commitment to bringing to market new and differentiated technologies for our customers." Wasson continued, "We are pleased to collaborate with Lavie Bio – a leader in the field of agriculture biologicals – as we continue to focus on accelerating commercialization of customer-centered innovation in this high-growth sector."